Table 3 IC50 Measurement of the GSK3β activity of 1,5-oxaza spiroquinone compound 2j in several ATP concentrations.
From: Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space
Compound | ATP concentration (µM) | ||||
|---|---|---|---|---|---|
1 | 10 | 50 | 100 | 200 | |
2ja | 2.65 | 3.53 | 3.79 | 4.04 | 3.45 |
Staurosporineb | 5.05 | 6.49 | 19.44 | 32.24 | 140.20 |